Additionally, there are studies in which PPARγ expression and the effect of ESA on disease pathogenesis have been evaluated in breast cancer cell lines [27], [68], pre-adipocytes [69], and colon cancer cell lines [70]. Here, PPARG is linked to malignant colon neoplasm.